Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Pediatric IBD
Summary
The NIH has registered a clinical trial (NCT07533890) to study fecal microbiome and metabolic profiles in children and adolescents with inflammatory bowel disease upon multi-strain probiotic supplementation. The study will enroll participants and begin interventions on April 16, 2026.
What changed
The NIH has registered a new clinical trial on ClinicalTrials.gov to investigate the effects of multi-strain probiotic supplementation on intestinal microbiome and metabolic profiles in pediatric patients with inflammatory bowel disease. The study will use probiotic formula as an active intervention compared to observation in children and adolescents.
Healthcare providers and clinical investigators should note this upcoming trial for awareness of emerging probiotic research in pediatric gastroenterology. Patients and families seeking enrollment in IBD microbiome studies may benefit from monitoring ClinicalTrials.gov for updated enrollment information as the April 2026 start date approaches.
What to do next
- Monitor for updates
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease
N/A NCT07533890 Kind: NA Apr 16, 2026
Abstract
In this study the intestinal microbiome and metabolic profiles of patients with inflammatory bowel disease will be determined upon probiotic intervention.
Conditions: Inflamatory Bowel Disease
Interventions: Probiotic Formula, Observation
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.